Apollomics Inc (APLM)

Jun 12, 2025

New Age Metals (OTCMKTS:NMTLF) Trading 1.2% Higher – Here’s Why - Defense World

Jun 12, 2025

Jun 12, 2025

Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Decreases By 87.9% - Defense World

Jun 12, 2025

Jun 12, 2025

Orca Energy Group (OTCMKTS:ORXGF) Trading 1.4% Higher – What’s Next? - Defense World

Jun 12, 2025

Jun 10, 2025

(APLM) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 10, 2025

May 31, 2025

Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Increases By 75.8% - Defense World

May 31, 2025

May 29, 2025

How the (APLM) price action is used to our Advantage - news.stocktradersdaily.com

May 29, 2025

May 23, 2025

Apollomics (APLM) Trading Halted Due to Volatility | APLM Stock News - GuruFocus

May 23, 2025

May 23, 2025

Apollomics (APLM) Stock Trading Resumes | APLM Stock News - GuruFocus

May 23, 2025

May 08, 2025

(APLM) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 08, 2025

Apr 16, 2025

Short Interest in Apollomics, Inc. (NASDAQ:APLMW) Decreases By 44.4% - Defense World

Apr 16, 2025

Apr 15, 2025

APLM stock touches 52-week low at $4.71 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

APLM stock touches 52-week low at $4.71 amid sharp annual decline - Investing.com Canada

Apr 15, 2025

Apr 06, 2025

(APLM) Investment Analysis - news.stocktradersdaily.com

Apr 06, 2025

Apr 04, 2025

APLM stock touches 52-week low at $6 amid market challenges - Investing.com Australia

Apr 04, 2025

Apr 03, 2025

Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress - The Manila Times

Apr 03, 2025

Apr 03, 2025

Apollomics Achieves Major Clinical Win: 43% Response Rate Plus New $10M Partnership Deal Extends Runway - Stock Titan

Apr 03, 2025

Apr 02, 2025

Apollomics and LaunXP ink $50 M deal for NSCLC treatment in Asia - BioSpectrum Asia

Apr 02, 2025

Apr 01, 2025

Apollomics and LaunXP agree on NSCLC treatment in Asia - Yahoo

Apr 01, 2025

Apr 01, 2025

Apollomics, Inc. (NASDAQ:APLMW) Sees Significant Growth in Short Interest - Defense World

Apr 01, 2025

Mar 31, 2025

Apollomics, LaunXP enter development, commercial agreement for Vebreltinib - MSN

Mar 31, 2025

Mar 31, 2025

Apollomics Signs Exclusive Development, Commercialization Deal for Vebreltinib in Asia - MarketScreener

Mar 31, 2025

Mar 31, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Mar 31, 2025

Mar 31, 2025

Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

$60M Deal: Apollomics' Lung Cancer Drug Breakthrough Expands Across Asia - Stock Titan

Mar 31, 2025

Mar 28, 2025

Better Artificial Intelligence Stock: SoundHound AI vs. C3.ai - The Globe and Mail

Mar 28, 2025

Mar 28, 2025

Apollomics Inc. and LaunXP International Co., Ltd., Affiliate of LaunXP Biomedical Co., Ltd. Announce Development and Commercialization Agreement for Vebreltinib - marketscreener.com

Mar 28, 2025

Mar 24, 2025

Why Coinbase (COIN) Stock Is Trading Up Today - The Globe and Mail

Mar 24, 2025

Mar 17, 2025

Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update - Defense World

Mar 17, 2025

Mar 07, 2025

These Were the 2 Top-Performing Stocks in the S&P 500 in February 2025 - The Globe and Mail

Mar 07, 2025

Mar 06, 2025

(APLM) Trading Advice - Stock Traders Daily

Mar 06, 2025

Mar 02, 2025

Apollomics, Inc. (NASDAQ:APLMW) Sees Large Decrease in Short Interest - Defense World

Mar 02, 2025

Mar 01, 2025

APLM Stock Hits 52-Week Low at $6.2 Amid Steep Yearly Decline - Investing.com Australia

Mar 01, 2025

Feb 28, 2025

APLM Stock Hits 52-Week Low at $6.2 Amid Steep Yearly Decline By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 25, 2025

GlycoMimetics ends key agreement; board members, executives depart - Investing.com

Feb 25, 2025

Feb 12, 2025

APLM stock touches 52-week low at $6.38 amid market challenges - MSN

Feb 12, 2025

Feb 11, 2025

APLM stock touches 52-week low at $6.38 amid market challenges By Investing.com - Investing.com South Africa

Feb 11, 2025

Feb 01, 2025

Objective long/short (APLM) Report - Stock Traders Daily

Feb 01, 2025

Jan 29, 2025

Apollomics, Inc. (NASDAQ:APLMW) Sees Significant Decrease in Short Interest - Defense World

Jan 29, 2025

Dec 20, 2024

Apollomics Shares Down in Premarket After Leukemia Drug Misses Phase-3 Targets - MarketWatch

Dec 20, 2024

Dec 20, 2024

Apollomics Announces Top-line Results for Phase 3 Bridging - GlobeNewswire

Dec 20, 2024

Dec 20, 2024

Apollomics, after giving up on GlycoMimetics' leukemia therapy, posts drug's latest phase 3 fail - Fierce Biotech

Dec 20, 2024

Dec 10, 2024

Apollomics Regains Compliance with Nasdaq’s Minimum Bid Price Requirement - GlobeNewswire

Dec 10, 2024

Nov 26, 2024

APLM Stock Plummets to 52-Week Low, Hits $8.01 Amid Market Turbulence - Investing.com

Nov 26, 2024

Nov 21, 2024

Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split - GlobeNewswire

Nov 21, 2024

Nov 19, 2024

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLMA Must-Watch This Week! - Marketscreener.com

Nov 19, 2024

Sep 16, 2024

Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024 - Yahoo Finance

Sep 16, 2024

Sep 04, 2024

Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance

Sep 04, 2024

Sep 03, 2024

Apollomics Inc.: Directors (Cayman Islands, 2024) - OffshoreAlert

Sep 03, 2024

Aug 14, 2024

Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress - GlobeNewswire

Aug 14, 2024

Aug 13, 2024

Apollomics Announces Positive Preliminary Data of - GlobeNewswire

Aug 13, 2024

Aug 08, 2024

Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference - Yahoo Finance

Aug 08, 2024